445

N-[oxo(phenylamino)acetyl]-beta-D-glucopyranosylamine

Created:	2008-04-23
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where 445 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	41
Chiral Atom Count	5
Bond Count	42
Aromatic Bond Count	6

2D diagram of 445

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[oxo(phenylamino)acetyl]-beta-D-glucopyranosylamine
Synonyms	N-[oxo(phenylamino)acetyl]-beta-D-glucosylamine; N-[oxo(phenylamino)acetyl]-D-glucosylamine; N-[oxo(phenylamino)acetyl]-glucosylamine
Systematic Name (OpenEye OEToolkits)	N-phenyl-N'-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethanediamide
Formula	C₁₄ H₁₈ N₂ O₇
Molecular Weight	326.302
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(NC1OC(C(O)C(O)C1O)CO)C(=O)Nc2ccccc2
SMILES	CACTVS	3.341	OC[CH]1O[CH](NC(=O)C(=O)Nc2ccccc2)[CH](O)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)NC(=O)C(=O)NC2C(C(C(C(O2)CO)O)O)O
Canonical SMILES	CACTVS	3.341	OC[C@H]1O[C@@H](NC(=O)C(=O)Nc2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)NC(=O)C(=O)N[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O
InChI	InChI	1.03	InChI=1S/C14H18N2O7/c17-6-8-9(18)10(19)11(20)14(23-8)16-13(22)12(21)15-7-4-2-1-3-5-7/h1-5,8-11,14,17-20H,6H2,(H,15,21)(H,16,22)/t8-,9-,10+,11-,14-/m1/s1
InChIKey	InChI	1.03	MWGDULHTYQLGFY-YNXVLUOKSA-N

Related Resource References

Resource Name	Reference
PubChem	25227370
ChEMBL	CHEMBL1230224

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.